Followers | 54 |
Posts | 3704 |
Boards Moderated | 0 |
Alias Born | 01/25/2019 |
Monday, February 15, 2021 12:13:29 PM
Steve Rotman quietly added RXAIR FEC ROTMANS and started eliminating debt! Now RXAIR will be an internationally recognized name. Other RX models and products will be added with great success!
I have always said that FEC will the big game changer for the company and I still believe that.
Add the huge worldwide licensing deal with VYTEX ($$$) and the success of RXAIR ($$$) the company will finally have the recourses to catapult FEC into stardom. ($$$$$$$$$) The magnitude of FEC'S potential uses will shock everyone all over the world. The unlimited applications and needs for the FEC Hughes Reactor are so powerful and valuable most people still don't have a clue of what it's worth!
(Don't forget the new Rotmans. Another $50M-$100M GROSS REVENUE to add to the VYST corporate account.)
I suggest that everyone remember the massive future of FEC!
This company and the eventual PPS are going to stun Millions$ of people! No one will ever believe that it was just .05 cents I can promise you that!
IMO-$VYST-RXAIR-VYTEX-FEC-NEW ROTMANS!
As Frank Sinatra sang "Some people get their kicks stompin on a dream!"
Is it possible that anyone would continuously say horrible things about a company that they own and expect the share price to rise? NOT!
Recent VYST News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 08:06:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/29/2023 11:01:23 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 10:21:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/28/2023 07:36:12 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/26/2023 06:46:25 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/26/2023 06:41:50 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/10/2023 09:14:55 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM